Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital.

Dig Dis Sci 2018 12 4;63(12):3241-3249. Epub 2018 Aug 4.

Section of Gastroenterology, Evans Department of Medicine, Boston University School of Medicine, Boston Medical Center, 85 East Concord Street 7th Floor, Boston, MA, 02118, USA.

Background: Treatment of hepatitis C virus (HCV) with direct-acting antiviral (DAA) regimens has resulted in high rates of sustained virologic response (SVR). Treatment of vulnerable populations may be improved by incorporating an on-site intensive specialty pharmacy (ON-ISP).

Aims: To describe outcomes of HCV treatment at a safety-net hospital and proportion of subjects achieving SVR for those using the ON-ISP compared to an off-site pharmacy (OFF-SP).

Methods: A retrospective cohort study of 219 subjects treated for HCV with DAA at Boston Medical Center was conducted. Subject characteristics, virologic response, and pharmacy services used were recorded. We used multivariable logistic regression to test the association between ON-ISP and SVR after adjusting for covariates.

Results: SVR occurred in 71% of subjects by intention-to-treat (73% among ON-ISP users vs 57% among OFF-SP users) and 95% completing treatment per-protocol (96% among ON-ISP users vs 87% among OFF-SP users). Adjustment for age, sex, ethnicity, insurance, fibrosis, prior treatment, and MELD revealed an increased likelihood of SVR among users of ON-ISP: OR 6.0 (95% CI 1.18-31.0). No significant difference in treatment delay or adverse events was seen among users of either pharmacy type.

Conclusions: HCV treatment with DAA was well tolerated, but the rate of SVR was low (71%) compared to trials. This was due to loss to follow-up, as the per-protocol rate of SVR was much higher (95%). Use of ON-ISP was associated with an increase in SVR and may be valuable for improving care for vulnerable populations.

Download full-text PDF

Source
http://link.springer.com/10.1007/s10620-018-5231-0
Publisher Site
http://dx.doi.org/10.1007/s10620-018-5231-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770976PMC
December 2018
13 Reads

Publication Analysis

Top Keywords

on-isp users
8
rate svr
8
hcv treatment
8
safety-net hospital
8
virologic response
8
off-sp users
8
treatment
8
treatment vulnerable
8
svr
8
vulnerable populations
8
users
6
on-isp
6
users pharmacy
4
on-isp svr
4
pharmacy services
4
svr adjusting
4
treatment daa
4
recorded multivariable
4
services recorded
4
multivariable logistic
4

References

(Supplied by CrossRef)

N Afdhal et al.
N Engl J Med 2014

LI Backus et al.
Hepatology 2016

FA Berden et al.
PLoS One 2016

E Chamorro-de-Vega et al.
Ann Pharmacother 2016

R Flisiak et al.
Aliment Pharmacol Ther 2016

GN Ioannou et al.
Gastroenterology 2016

NA Terrault et al.
Gastroenterology 2016

TM Welzel et al.
Gut 2017

TM Welzel et al.
Gut 2016

RJ Wong et al.
J Viral Hepat 2017

BE Yee et al.
BMJ Open Gastroenterol 2016

Similar Publications